{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:47:29Z","timestamp":1777092449656,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fonds National de la Recherche Scientifique"},{"name":"T\u00e9l\u00e9vie","award":["7.4520.15"],"award-info":[{"award-number":["7.4520.15"]}]},{"name":"T\u00e9l\u00e9vie","award":["7.4648.12F"],"award-info":[{"award-number":["7.4648.12F"]}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.radonc.2017.08.018","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T22:20:01Z","timestamp":1505254801000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines"],"prefix":"10.1016","volume":"124","author":[{"given":"Karolin","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Bol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.08.018_b0005","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.hoc.2008.08.006","article-title":"Human papillomavirus in HNSCC: recognition of a distinct disease type","volume":"22","author":"Vidal","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.radonc.2017.08.018_b0010","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/sj.bjc.6605944","article-title":"Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy","volume":"103","author":"Hong","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2017.08.018_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00066-014-0753-7","article-title":"Improved survival in HPV\/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapy","volume":"191","author":"Heiduschka","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2017.08.018_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ejso.2016.12.002","article-title":"Genomic sequencing and precision medicine in head and neck cancers","volume":"43","author":"Hoesli","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.21037\/atm.2016.03.34","article-title":"The emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applications","volume":"4","author":"Economopoulou","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archoto.2010.211","article-title":"Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer","volume":"136","author":"Wansom","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2017.08.018_b0040","first-page":"e89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"20","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.radonc.2017.08.018_b0045","first-page":"24","article-title":"Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma","volume":"5","author":"Russell","year":"2013","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0050","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.coi.2008.05.007","article-title":"Immunogenic cancer cell death: a key-lock paradigm","volume":"20","author":"Tesniere","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.radonc.2017.08.018_b0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1387\/ijdb.150061pa","article-title":"Immunogenic cell death","volume":"59","author":"Garg","year":"2015","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.radonc.2017.08.018_b0060","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fimmu.2015.00588","article-title":"Molecular and translational classifications of DAMPs in immunogenic cell death","volume":"6","author":"Garg","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2017.08.018_b0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0075","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.radonc.2017.08.018_b0085","doi-asserted-by":"crossref","first-page":"149185","DOI":"10.1155\/2014\/149185","article-title":"Chronic inflammation and cytokines in the tumor microenvironment","volume":"2014","author":"Landskron","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12950-015-0058-3","article-title":"Portrait of inflammatory response to ionizing radiation treatment","volume":"12","author":"Di Maggio","year":"2015","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.radonc.2017.08.018_b0095","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.160.7.3081","article-title":"Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection","volume":"160","author":"Celluzzi","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.radonc.2017.08.018_b0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20040741","article-title":"CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells","volume":"385","author":"Cao","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.radonc.2017.08.018_b0105","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.molimm.2011.04.018","article-title":"Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells","volume":"48","author":"Seo","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.radonc.2017.08.018_b0110","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1002\/ijc.29112","article-title":"Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines","volume":"136","author":"Olthof","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2017.08.018_b0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.18632\/oncotarget.1719","article-title":"Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing","volume":"5","author":"Gameiro","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2017.08.018_b0120","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1038\/onc.2014.424","article-title":"A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription","volume":"34","author":"Musahl","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2017.08.018_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/366076a0","article-title":"B70 antigen is a second ligand for CTLA-4 and CD28","volume":"366","author":"Azuma","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2017.08.018_b0130","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/sj.cdd.4402201","article-title":"Calreticulin exposure is required for the immunogenicity of \u03b3-irradiation and UVC light-induced apoptosis","volume":"14","author":"Obeid","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.radonc.2017.08.018_b0135","doi-asserted-by":"crossref","first-page":"26841","DOI":"10.18632\/oncotarget.4754","article-title":"Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal","volume":"6","author":"Garg","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2017.08.018_b0140","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-12-0851","article-title":"Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma","volume":"72","author":"Suzuki","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0145","doi-asserted-by":"crossref","first-page":"e28518","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.radonc.2017.08.018_b0150","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1038\/cddis.2010.82","article-title":"Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia","volume":"2","author":"Wemeau","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2017.08.018_b0155","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-011-1146-8","article-title":"Calreticulin as a potential diagnostic biomarker for lung cancer","volume":"61","author":"Liu","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2017.08.018_b0160","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1158\/0008-5472.CAN-15-1142","article-title":"Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis","volume":"76","author":"Fucikova","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.oraloncology.2013.01.003","article-title":"Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma","volume":"49","author":"Chiang","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0170","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.3892\/ol.2017.6062","article-title":"Calreticulin is a novel independent prognostic factor for oral squamous cell carcinoma","volume":"13","author":"Harada","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2017.08.018_b0175","doi-asserted-by":"crossref","first-page":"143ra99","DOI":"10.1126\/scitranslmed.3003807","article-title":"Cardiac glycosides exert anticancer effects by inducing immunogenic cell death","volume":"4","author":"Menger","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.radonc.2017.08.018_b0180","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.ejca.2010.07.016","article-title":"Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance","volume":"46","author":"Liu","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2017.08.018_b0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.oraloncology.2011.12.009","article-title":"HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer","volume":"48","author":"Wild","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0190","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12032-014-0316-x","article-title":"Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma","volume":"31","author":"Qiu","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0195","first-page":"1369","article-title":"Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer","volume":"5","author":"Chen","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0200","first-page":"45","article-title":"Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma","volume":"20","author":"Pries","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.radonc.2017.08.018_b0205","first-page":"2481","article-title":"Cytokine changes in response to radio-\/chemotherapeutic treatment in head and neck cancer","volume":"33","author":"Reers","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1748-717X-7-64","article-title":"Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies","volume":"7","author":"Citrin","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0215","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/pr401009f","article-title":"Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection","volume":"13","author":"Guerrera","year":"2014","journal-title":"J Proteome Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0220","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2017.08.018_b0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.oraloncology.2004.05.006","article-title":"Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck","volume":"41","author":"Kacani","year":"2005","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0230","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"Ward","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2017.08.018_b0235","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2017.08.018_b0240","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1368-8375(03)00076-9","article-title":"Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes","volume":"39","author":"Kacani","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2017.08.018_b0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.10669","article-title":"Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer","volume":"102","author":"Mellin","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2017.08.018_b0250","first-page":"133","article-title":"Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer","volume":"36","author":"Ritt\u00e0","year":"2013","journal-title":"New Microbiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017325410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:13:40Z","timestamp":1692990820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017325410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0167814017325410"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.08.018","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}